Search

everythinglearnresearchcommunity

for

Search:↓

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Topical tofacitinib is effective and safe for treating alopecia areata.

Corin helps control salt and sweat release in sweat glands.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

PRP is an effective and safe treatment for hair loss in women.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Baricitinib is the most effective treatment for alopecia areata.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

Different conditions affect how hair proteins assemble, and certain mutations can change their structure.

Low vitamin D levels are common in people with Alopecia Areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

People with Alopecia areata often have lower vitamin D levels, which may be linked to the severity of their condition.

AB+ blood group is more common in alopecia areata patients.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

People with alopecia areata often have lower vitamin D levels than healthy people.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Intralesional triamcinolone acetonide is preferred for treating patchy alopecia areata due to fewer side effects.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Certain hair and scalp features can predict the severity of alopecia areata.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.